Daniel Stauder
Stock Analyst at Citizens JMP
(4.07)
# 1,570
Out of 4,355 analysts
53
Total ratings
48.7%
Success rate
19.8%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Stauder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AORT Artivion | Maintained: Buy | $53 → $48 | $22.19 | +116.31% | 10 | May 8, 2026 | |
| LMAT LeMaitre Vascular | Maintained: Buy | $118 → $127 | $94.65 | +34.18% | 11 | May 6, 2026 | |
| ATRC AtriCure | Maintained: Buy | $60 → $52 | $27.67 | +87.93% | 15 | Feb 18, 2026 | |
| STXS Stereotaxis | Initiated Coverage: Buy | $4 | $1.98 | +102.02% | 1 | Dec 16, 2025 | |
| STIM Neuronetics | Reiterated: Buy | $3 → $7 | $1.54 | n/a | 6 | Mar 5, 2025 | |
| AVNS Avanos Medical | Reiterated: Hold | n/a | $24.80 | n/a | 10 | Feb 28, 2025 |
Artivion
May 8, 2026
Maintained: Buy
Price Target: $53 → $48
Current: $22.19
Upside: +116.31%
LeMaitre Vascular
May 6, 2026
Maintained: Buy
Price Target: $118 → $127
Current: $94.65
Upside: +34.18%
AtriCure
Feb 18, 2026
Maintained: Buy
Price Target: $60 → $52
Current: $27.67
Upside: +87.93%
Stereotaxis
Dec 16, 2025
Initiated Coverage: Buy
Price Target: $4
Current: $1.98
Upside: +102.02%
Neuronetics
Mar 5, 2025
Reiterated: Buy
Price Target: $3 → $7
Current: $1.54
Upside: n/a
Avanos Medical
Feb 28, 2025
Reiterated: Hold
Price Target: n/a
Current: $24.80
Upside: n/a